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ABSTRACT 
Tight junctions (TJs), which are the most apically located of the intercellular junctional com-
plexes, have a barrier function and a fence function. Recent studies show that they also parti-
cipate in signal transduction mechanisms. TJs are modulated by intracellular signaling path-
ways including protein kinase C, mitogen-activated protein kinase, and NF-κB, to affect the 
epithelial barrier function in response to diverse stimuli. TJs are also regulated by various cy-
tokines, growth factors, and hormones via signaling pathways. To investigate the regulation 
of TJ molecules via signaling pathways in human epithelial cells under normal and pathologi-
cal conditions, we established a novel model of human telomerase reverse transcriptase-
transfected human epithelial cells. In this review, we describe the recent progress in our un-
derstanding of the role of TJs for signal transduction under normal conditions in upper airway 
epithelium, pancreatic duct epithelial cells, hepatocytes, and endometrial epithelial cells, and 
in pathological conditions including cancer and infection. 
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INTRODUCTION 
Tight junctions (TJs), which are the most 
apically located of the intercellular junctional 
complexes, inhibit solute and water flow 
through the paracellular space (termed the 
barrier function) (Gumbiner, 1993; Schnee-
berger et al., 1992). In addition, they separate 
the apical and basolateral cell surface do-
mains to establish cell polarity (termed the 
fence function) (Figure 1) (van Meer and 
Simons, 1986; Cereijido et al., 1998). Recent 
evidence shows that TJs participate in signal 
transduction mechanisms that regulate epi-
thelial cell proliferation, gene expression, 
differentiation, and morphogenesis (Balda 
and Matter, 2009). 
TJs are formed not only by the integral 
membrane proteins claudins, occludin, and 
junction adhesion molecules (JAMs) but also 
by several peripheral membrane proteins. 
These peripheral membrane proteins include 
the scaffold PDZ expression proteins zonula 
occludins (ZO)-1, -2, -3, multi-PDZ domain 
protein-1 (MUPP1), and membrane-associat-
ed guanylate kinase with inverted orientation 
(MAGI)-1, -2, -3. Furthermore, they com-
prise cell polarity molecules, such as 
ASIP/PAR-3, PAR-6, PALS-1, and PALS-1-
associated TJ (PATJ) and the non-PDZ-
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expressing proteins, cingulin, symplekin, 
ZONAB, GEF-H1, aPKC, PP2A, Rab3b, 
Rab13, PTEN, and 7 H6 (Schneeberger and 
Lynch, 2004; Tsukita et al., 2001; Sawada et 
al., 2003). The proteins ZO-1, -2, and -3 are 
members of the membrane-associated 
guanylate kinase (MAGUK) family of pro-
teins displaying a characteristic multidomain 
structure comprising SH3, guanylate kinase-
like (GUK), and multiple PDZ (PSD95–Dlg–
ZO1) domains (Anderson, 1996). ZO-1 and  
-2 are also closely associated with the 
polymerization of claudins (Umeda et al., 
2006). Tricellulin was first identified at tri-
cellular contacts with three epithelial cells 
and has been shown to have a barrier func-
tion (Ikenouchi et al., 2005). More recently, 
lipolysis-stimulated lipoprotein receptor 
(LSR) was identified as a tricellular TJ-
associated membrane protein that recruits 
tricellulin to tricellular TJs (Masuda et al., 
2011). 
The claudin family, which consists of at 
least 27 members, is solely responsible for 
forming TJ strands and has four transmem-
brane domains and two extracellular loops 
(Figure 1) (Tsukita et al., 2001; Mineta et al., 
2011). The first extracellular loop is the co-
receptor of hepatitis C virus (Meredith et al., 
2012), which influences the paracellular 
charge selectivity (Krug et al., 2012). The 
second extracellular loop is the receptor of 
Clostridium perfringens enterotoxin (CPE) 
(Fujita et al., 2000). In addition, because 
claudin-4 is also a high-affinity receptor of 
CPE (Katahira et al., 1997), full-length CPE 
with a direct cytotoxic effect and the C-
terminal receptor binding domain of CPE (C-
CPE) without a cytotoxic effect are em-
ployed for selective treatment and drug de-
livery against claudin-4-expressing cells 
(Michl et al., 2001; Saeki et al., 2009). 
Occludin, the first discovered integral 
membrane protein of TJs, is ubiquitously ex-
pressed at the most apically located basolat-
eral membranes and is the most reliable im-
munohistochemical marker for TJs (Tsukita 
et al., 2001; Furuse et al., 1993). Overex-
pression of occludin increases the barrier 
function, indicated by an increase in trans-
epithelial electric resistance (TER) in mam-
malian epithelial cells (Balda et al., 1996; 
McCarthy et al., 1996). However, TJ strands 
can be formed without occludin in some cell 
types, including occludin-deficient embryon-
ic stem cells (Hirase et al., 1997; Saitou et 
al., 1998). Moreover, an occludin-deficient 
mouse model does not display a perturbation 
of epithelial barrier function. However, a 
complex pathophysiological phenotype is 
observed, with growth retardation, chronic 
inflammation and hyperplasia of the gastric 
epithelium, calcification in the brain, testicu-
lar atrophy, loss of cytoplasmic granules in 
striated duct cells of the salivary gland, and 
thinning of the compact bone (Saitou et al., 
2000). Compared with claudins, occludin has 
a relatively long cytoplasmic C terminus 
containing several phosphorylation sites and 
a coiled-coil domain that probably interacts 
with compounds, including PKC-z, c-Yes, 
connexin26, and the regulatory subunit of 
phosphatidylinositol 3-kinase (PI3K) (Cum-
mins, 2012), as well as occludin itself, and 
ZO-1 and -3 (Schneeberger and Lynch, 
2004; Tsukita et al., 2001). Thus, research 
has suggested several roles of occludin in 
signal transduction, and its involvement in 
apoptosis has been reported (Murata et al., 
2005; Osanai et al., 2006). Furthermore, oc-
cludin is required for hepatitis C virus 
(HCV) infection, similar to claudins (Zeisel 
et al., 2011). 
JAMs (JAM-A, -B, -C, and -4) are im-
munoglobulin superfamily proteins ex-
pressed at cell junctions in epithelial and en-
dothelial cells, as well as on the surfaces of 
leukocytes, platelets, and erythrocytes (Mar-
tin-Padura et al., 1998). They are important 
for a variety of cellular processes including 
TJ assembly, leukocyte transmigration, 
platelet activation, angiogenesis, and adeno-
virus binding. Current evidence indicates 
that JAM-A dimerization is necessary for 
functional regulation of the cellular barrier 
(Monteiro and Parkos, 2012).  
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Figure 1(A): Schematic diagram of a tight 
junction. Tight junctions are the most apically 
located of the intercellular junctional complexes 
in vertebrate epithelial cell sheets. On transmis-
sion electron microscopy, tight junctions appear 
as a series of very close membrane appositions 
(so-called kissing points) between adjacent cells.  
 
 
Figure 1(B): Functions of tight junctions. 
Fence function: Separating the apical from the 
basolateral cell surface domains to establish cell 
polarity. Barrier function: Inhibiting solute and 
water flow through the paracellular space. Signal 
transduction: Regulating epithelial cell prolifera-
tion, gene expression, differentiation, and mor-
phogenesis 
 
 
TJs FOR SIGNAL TRANSDUCTION IN 
NORMAL EPITHELIAL CELLS 
TJs and signals in the upper respiratory 
tract 
The epithelium in the upper respiratory 
tract consists of pseudostratified ciliated co-
lumnar epithelial cells, including M cells 
(membranous or microfold cells), which are 
specialized for antigen uptake and form a 
continuous barrier against a wide variety of 
exogenous antigens (Holgate, 2008; Fuji-
mura, 2000; Kim et al., 2011; Nawijn et al., 
2011; Takano et al., 2008), and dendritic 
cells (DCs), which take up transported anti-
gens via M cells and present antigens for 
CD4+ T cells while maintaining the integrity 
of the airway epithelial barrier (Steinman et 
al., 1997; Yamanaka et al., 2003; Hammad 
and Lambrecht, 2011). The epithelium plays 
a crucial role as an interface of adaptive re-
sponses and innate responses via TJs, to pre-
vent invasion of inhaled environmental 
agents such as allergens and pathogens. Dy-
namic changes in TJs have been identified in 
human nasal mucosa affected by allergic rhi-
nitis or viral infection. 
The proliferation and storage of epithelial 
cells in primary cultures are known to be 
limited. We introduced the catalytic compo-
nent of telomerase, the human telomerase 
reverse transcriptase (hTERT) gene, into 
primary cultured human nasal epithelial cells 
(HNECs) (Kurose et al., 2007). The ectopic 
expression of hTERT in the epithelial cells 
resulted in greater growth potential and a 
longer lifespan of the cells. The cells had a 
small cobblestone appearance in phase-
contrast images and cilia-like structures, a 
differentiation marker of nasal epithelial 
cells, were observed on the surface of 
hTERT-transfected cells. The properties of 
the hTERT-transfected cells were similar to 
those of the cells in primary cultures (Kurose 
et al., 2007). In HNECs cultured in vitro us-
ing primary cultures and our established cul-
ture systems, TJ molecules and the barrier 
function are upregulated by various stimuli 
(Table 1). 
Protein kinase C (PKC) is a family of 
serine–threonine kinases known to regulate 
the epithelial barrier function (Tsukamoto et 
al., 1999; Andreeva et al., 2001; Seth et al., 
2007). PKC has been shown to induce both 
assembly and disassembly of TJs, depending 
on the cell type and the conditions of activa-
tion (Stuart and Nigam, 1995; Andreeva et 
al., 2001). The activation of PKC causes an 
increase in permeability in renal epithelial 
LLC-PK1 cells and Madin–Darby canine 
kidney (MDCK) cells (Ellis et al., 1992; 
Clarke et al., 2000). Conversely, it causes a 
decrease in permeability in the human colon 
carcinoma cell line HT29 (Sjö et al., 2003). 
Bryostatin enhances TJ barrier function in 
T84 cells through a PKC signaling pathway 
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(Yoo et al., 2003). PKC appears to regulate 
the subcellular localization, phosphorylation 
states, and transcription of several TJ-
associated proteins (Banan et al., 2005), alt-
hough the isozyme specificity has not been 
clearly elucidated. The isoforms can be di-
vided into three groups (Zeng, 2012): (1) the 
classic or conventional isozymes (α, βI, βII, 
and γ) are both Ca2+- and diacylglycerol 
(DAG)-dependent, (2) the novel (nPKC) iso-
zymes (δ, ε, θ, η, and μ) are Ca2+-
independent but DAG-dependent, and (3) the 
atypical isozymes (λ, τ, and ζ) are neither 
Ca2+- nor DAG-dependent. Activation of 
PKC by 12-O-tetradecanoylophorbol-13-
acetate (TPA) is known to cause increases in 
transcription of occludin, ZO-1, and claudin-
1 in T84 cells and melanoma cells (Weiler et 
al., 2005; Leotlela et al., 2007). 
To investigate the mechanisms of regula-
tion of TJs through a PKC signaling path-
way, HNECs were treated with TPA as a 
PKC activator (Koizumi et al., 2008). We 
found that short treatment with TPA greatly 
enhanced epithelial barrier function together 
with an increase in the expression of occlud-
in, ZO-1 and -2, and claudin-1 at the tran-
scriptional level. The upregulation of barrier 
function and TJ proteins was prevented by a 
pan-PKC inhibitor and the inhibitors of 
PKCδ and PKCθ but not PKCε (Koizumi et 
al., 2008). When we focused on the tran-
scriptional factor GATA family to investi-
gate the transcriptional mechanisms, upregu-
lation of ZO-1 and -2 by treatment with TPA 
was regulated by GATA-3 via a PKC signal-
ing pathway (Figure 2) (Koizumi et al., 
2008).
Table 1: Changes in TJ proteins and barrier function in human nasal epithelial cells (HNECs) in vitro 
(CL, claudins; Oc, occludin; TRIC, tricellulin) 
 
Figure 2: TPA, a PKC activator, increases tight junction barrier function together with upregulation of 
the tight junction proteins, occludin, zona occludens (ZO)-1 and -2, and claudin-1, at the transcriptional 
level in human nasal epithelial cells. It also affects the subcellular localization of the tight junction pro-
teins and the numbers of tight junction strands. PKC signaling enhances the barrier function via tran-
scriptional upregulation of tight junction proteins. 
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Peroxisome proliferator-activated recep-
tor (PPAR)γ is a nuclear hormone receptor 
superfamily member and a ligand-activated 
transcription factor that requires heterodi-
merization with the retinoid X receptor 
(RXR) to bind specific PPAR response ele-
ments (PPRE) located in promoter regions of 
target genes (Bensinger and Tontonoz, 
2008). Recently, PPARγ agonists have been 
shown to enhance barrier functions together 
with upregulation of TJ molecules in gastro-
intestinal epithelial cells, urothelial cells, and 
endothelial cells (Varley et al., 2006; Dubu-
quoy et al., 2003; Ponferrada et al., 2007; 
Ramakers et al., 2007; Huang et al., 2009). 
To investigate the effects of PPARγ agonists 
on the TJ barrier of HNECs, which highly 
express both PPARγ and TJ proteins, 
HNECs were treated with the PPARγ ago-
nists rosiglitazone and troglitazone. Treat-
ment with the PPARγ agonists enhanced the 
barrier function of hTERT-transfected 
HNECs together with the upregulation of TJ 
molecules claudin-1 and -4, occludin, and 
tricellulin at the transcriptional level. In ad-
dition, a significant increase in TJ strands 
was observed after treatment with rosiglita-
zone. Treatment with PPARγ agonists in-
duced the activity of phospho-PKC in 
hTERT-transfected HNECs. The upregula-
tion of the TJ molecules in hTERT-
transfected HNECs by rosiglitazone was in-
hibited not only by PPARγ antagonists but 
also by a pan-PKC inhibitor. These findings 
suggest that PPARγ agonists upregulate the 
barrier function of the TJs of HNECs via a 
PKC signaling pathway (Ogasawara et al., 
2010). 
TJs and signals in pancreatic duct  
epithelial cells 
To investigate the structure and regula-
tion of TJs in normal pancreatic epithelial 
cells, we established a novel model of 
hTERT-transfected human pancreatic ductal 
epithelial (HPDE) cells with an extended life 
span (Yamaguchi et al., 2010). In this culture 
system, hTERT–HPDE cells in serum-free 
conditioned medium have increased growth 
potential and a long lifespan. Treatment with 
FBS induces an increase in protein and 
mRNA of carbonic anhydrase (CA) II that is 
dependent on the FBS concentration, where-
as proteins of cytokeratin (CK) 7 and 19 are 
stably expressed independent of the FBS 
concentration. Claudin-1, -4, and -7; occlud-
in; JAM-A; and ZO-1 and -2 are induced by 
10% FBS together with an increase in the 
barrier function, and the upregulation is in-
hibited by a pan-PKC inhibitor (Table 2) 
(Yamaguchi et al., 2010).  
The TJ molecules and the barrier func-
tion induced by FBS in hTERT–HPDE cells 
are partly regulated via a PKC pathway. 
Treatment with TPA-enhanced expression of 
most TJ proteins (Yamaguchi et al., 2010). 
In particular, claudin-4 and -18 were mark-
edly induced by TPA at the transcriptional 
level, together with an increase in TJ strands 
(Yamaguchi et al., 2010). The upregulation 
of TJ proteins by TPA was completely inhib-
ited by a pan-PKC inhibitor (GF109203X). 
A PKCθ inhibitor (myristoylated PKCθ 
pseudosubstrate peptide inhibitor) prevented 
upregulation of claudin-18 by TPA, a PKCα
 
 
Table 2: Changes in TJ proteins and barrier function in normal human pancreatic duct epithelial 
(HPDE) cells via PKC and JNK pathways (CL, claudins; Oc, occludin; TRIC, tricellulin) 
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inhibitor prevented upregulation of claudin-4 
and -18 by TPA, and a PKCδ inhibitor (rott-
lerin) prevented upregulation of claudin-7 
and -18, occludin and ZO-1 and -2 by TPA 
(Figure 3) (Yamaguchi et al., 2010). Accord-
ing to GeneChip analysis, upregulation of 
transcription factor E74-like factor (ELF) 3 
occurs in both fetal bovine serum- and TPA-
treated cells. ELF3 belongs to the ELF sub-
family of the ETS transcription factors, but it 
is distinguished from most ETS family 
members by its expression pattern, which is 
specific in epithelial tissues of the lung, liv-
er, kidney, pancreas, prostate, small intes-
tine, and colon mucosa (Tymms et al., 1997). 
ELF3 controls intestinal epithelial differenti-
ation (Jedlicka et al., 2008) and the expres-
sion of claudin-7 in epithelial structures in 
synovial sarcoma is regulated by ELF3 
(Kohno et al., 2006). In hTERT–HPDE cells, 
ELF3 mRNA is increased by TPA, and a 
pan-PKC inhibitor prevents upregulation of 
ELF3 mRNA by TPA (Yamaguchi et al., 
2010). When knockdown of ELF3 was in-
duced by small interfering RNAs (siRNAs) 
in hTERT–HPDE cells, upregulation of 
claudin-7 by TPA was inhibited. In sum-
mary, claudin-7 in normal HPDE cells may 
be regulated via a PKCδ–ELF3 pathway 
(Figure 3). 
 
Figure 3: Diagram showing the regulation of 
tight junction molecules in hTERT–HPDE cells 
via PKC isoforms. CL, claudin; Oc, occludin 
 
TJs and signals in hepatocytes 
The TJs of hepatocytes play a crucial role 
in keeping bile in bile canaliculi, away from 
the blood circulation. This role is referred to 
as the blood–biliary barrier (Kojima et al., 
2003). In primary rat hepatocytes, changes in 
claudin-1 and -2 and occludin induced by 
growth factors [epidermal (EGF), hepatocyte 
(HGF), and transforming (TGF-β)] and cyto-
kines interleukin (IL)-1β and oncostatin M 
(OSM) are regulated via distinct signal 
transduction pathways (Table 3) (Kojima et 
al., 2004, 2008; Yamamoto et al., 2004; 
Imamura et al., 2007). Furthermore, in im-
mortalized mouse hepatocytes, upregulation 
of claudin-2 via phosphatidylinositol 3 (PI3) 
kinase and PKC by treatment with OSM, and 
downregulation of claudin-2 via mitogen-
activated protein (MAP) kinase and p38 
MAP kinase by transfection with Raf-1 are 
observed (Table 3) (Lan et al., 2004; Imamu-
ra et al., 2007). These observations indicate 
that in hepatocytes, the TJ proteins claudin-1 
and -2, and occludin are regulated by various 
cytokines and growth factors via distinct sig-
nal transduction pathways. In addition, it is 
thought that the p38 MAP kinase pathway 
plays a crucial role in the regulation of clau-
din-1 and -2 in hepatocytes. When primary 
cultured rat hepatocytes were treated with 
the p38 MAP kinase activator anisomycin, 
downregulation of claudin-1 was observed 
(Kojima et al., 2003). Furthermore, a p38 
MAP-kinase inhibitor prevented downregu-
lation of claudin-1 by EGF in primary cul-
tured rat hepatocytes (Table 3) (Yamamoto 
et al., 2005). In the regenerating rat liver, 
treatment with a p38 MAP kinase inhibitor 
enhanced the upregulation of claudin-1 by 
partial hepatectomy (Table 3) (Kojima et al., 
2003; Yamamoto et al., 2005). Although the 
reason for this discrepancy between the in 
vitro and in vivo is yet unclear, the p38 MAP 
kinase pathway may be important for the 
formation of TJs during the proliferation of 
hepatocytes and regeneration of the liver. 
In primary cultures of occludin-deficient 
mouse hepatocytes, claudin-2 expression and 
apoptosis are induced by downregulation of 
the activation of MAP kinase and Akt. In 
hepatic cell lines derived from occludin-
deficient mice, claudin-2 expression and se-
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Table 3: Signal transduction to TJ proteins in hepatocytes [EGF, epidermal growth factor; HGF, 
hepatocyte growth factor; OSM, oncostatin M; (1), primary cultures of rat hepatocytes; (2), Raf-1 im-
mortalized mouse hepatocytes; PH, partial hepatectomy in rat livers.] 
 
 
 
rum-free induced apoptosis are also in-
creased by downregulation of the activation 
of MAP kinase and Akt. Furthermore, in he-
patic cell lines transiently transfected with 
mouse and rat occludin genes, induction of 
claudin-2 expression and apoptosis are inhib-
ited, with increases in the activation of MAP 
kinase and Akt. These findings show that 
occludin plays a crucial role in claudin-2-
dependent TJ function and apoptosis involv-
ing the MAP kinase–Akt and PI3-kinase–
Akt signaling pathways in hepatocytes (Mu-
rata et al., 2005). 
The development of polarity in hepato-
cytes, which results in bile canalicular for-
mation, is regulated by various kinases in 
response to extracellular signals. The serine–
threonine kinase PAR1b/EMK1/MARK2 
regulates bile canalicular formation in hepa-
toma cell lines, although the inhibition of 
bile canalicular formation by knockdown of 
PAR1b is weak (Cohen et al., 2004, 2007). 
Furthermore, Rho kinase, myosin-II, and 
p44/42 MAP kinase, the first identified fac-
tors, are involved in hepatocyte-derived ex-
tracellular matrix (ECM)-mediated multicel-
lular patterning and bile canalicular luminal 
morphogenesis in HepG2 cells (Herrema et 
al., 2006). PI3 kinase and p38 MAP kinase 
control taurocholate (ursodeoxycholate)-
induced trafficking of ATP-dependent 
transport to the canalicular surface in the rat 
liver, isolated hepatocytes, and hepatic cell 
lines (Misra et al., 1998; Sai et al., 1999; 
Kubitz et al., 2004). The serine–threonine 
kinase LKB1/PAR4 is mutated in most cases 
of Peutz–Jeghers syndrome, in which benign 
hamartomas and a high frequency of malig-
nant tumors develop (Cohen et al., 2004). 
The phosphorylation of LKB1 acts as a mas-
ter kinase that activates PAR1 polarity ki-
nase and AMP kinase (Baas et al., 2004; Xie 
et al., 2006). AMP kinase is known to not 
only act as a sensor of cellular energy status 
but to also regulate TJ assembly and epithe-
lial polarity (Zhang et al., 2006; Mirouse et 
al., 2007; Zheng and Cantley, 2007). By 
knockdown of claudin-2, upregulation of 
pLKB1, pp44/42 MAP kinase, pAkt, and 
pp38 MAP kinase was unexpectedly ob-
served, together with inhibition of bile cana-
licular formation (Son et al., 2009). These 
findings indicate that signaling from TJ pro-
teins may be important as a subcellular sys-
tem of bile canalicular formation. 
 
TJs and signals in endometrial epithelial 
cells 
Normal human endometrial epithelial 
(HEE) cells show a typical polarized pheno-
type during the proliferative phase of the 
menstrual cycle, which is controlled by 17β-
estradiol (E2), and during the secretory 
phase, which is predominantly governed by 
progesterone (P4), when the epithelial cells 
become receptive for implantation (Lessey, 
1998). A redistribution of desmosomes and 
adherens junctions in HEE cells in vivo is 
observed during the menstrual cycle (Buck et 
al., 2012). The action of E2 and P4 is primar-
ily mediated by their nuclear receptors, ab-
breviated as estrogen receptor (ER) and pro-
gesterone receptor (PR). The steroids E2 and 
P4 interact with their respective receptors 
and activate them to act as transcription fac-
tors (Bulun et al., 2012). However, the 
mechanism of sex hormone regulation of TJs 
in normal HEE cells remains unclear. To in-
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vestigate the regulation of TJs in HEE cells, 
we isolated and cultured epithelial and stro-
mal cells from human endometrium (Someya 
et al., 2013). In primary cultured HEE cells 
but not stromal cells, claudin-1, -3, -4, and  
-7, and occludin were detected together with 
ERα and PR. Embryo implantation requires 
that the apical plasma membrane of uterine 
epithelial cells acquires adhesiveness and 
that epithelial cell polarity is maintained. 
This process, referred to as the fence func-
tion, is thought to play a crucial role in em-
bryo implantation (Thie et al., 1996). In pri-
mary cultured HEE cells, all TJ proteins, in-
cluding claudin-3 and -4, were upregulated 
by P4 and the upregulation was inhibited by 
E2. The barrier function but not the fence 
function in HEE cells was downregulated by 
P4, which also inhibited the proliferation of 
HEE cells. Regardless of the upregulation of 
TJ proteins and the inhibition of cell prolif-
eration by P4, a downregulation of the barri-
er function was observed. In addition, we 
found that the formation of stress fibers, 
demonstrated by F-actin staining, was in-
duced by P4. P4 increases stress fiber for-
mation via PAR1 and the alteration of the 
actin organization results in a decrease in the 
barrier function (Camussi et al., 1991; Diaz 
et al., 2012). The decrease in the barrier 
function caused by P4 signaling in normal 
HEE cells may contribute to cytoskeletal re-
modeling. The finding that the fence func-
tion of normal HEE cells is not affected by 
sex hormones may be associated with the 
maintenance of embryo implantation. 
 
TJs FOR SIGNAL TRANSDUCTION IN 
HUMAN DISEASE 
Infectious disease 
An indispensable role of TJs in pathogen 
infection has been widely demonstrated be-
cause disruption of TJs leads to a distinct 
increase in paracellular permeability and po-
larity defects, which facilitate viral or bacte-
rial entry and spread. In addition, some pro-
teins comprising TJs work as receptors for 
viruses, and extracellular stimuli, pathogenic 
bacteria, and viruses target and affect the 
function of TJs, leading to disease (Sawada, 
2013). 
Claudin-3 and -4 are receptors for CPE, 
which is a common cause of food poisoning 
(Katahira et al., 1997; Fujita et al., 2000). 
When CPE binds claudin-4 expressed in 
MDCK cells, the complexes internalize like 
other ligand receptor complexes, and the 
function of TJs becomes disordered (Sonoda 
et al., 1999). It is interesting that this phe-
nomenon is observed only when the basolat-
eral surface of the cell is exposed to CPE 
(Maeda et al., 2012). The Helicobacter pylo-
ri toxin CagA causes an increase in paracel-
lular permeability of intestinal cells by inac-
tivating PAR1/MARK kinase (Saadat et al., 
2007). As a result, the barrier function of 
gastric foveolar epithelium deteriorates and 
microvilli disappear (Suzuki et al., 2002).  
The airway epithelium, which has a well-
developed barrier regulated by TJs, is the 
first line of defense during respiratory virus 
infection. Moreover, TJs include targets or 
receptors of viruses such as claudin-1 and 
occludin as coreceptors of HCV, JAM as a 
reovirus receptor, and the coxsackie and ad-
enovirus receptor (CAR) (Guttman and Fin-
lay, 2009). In HNECs, rhinovirus infection 
decreases expression of TJ molecules ZO-1, 
occludin, and claudin-1 and reduces barrier 
function (Yeo et al., 2010). Respiratory syn-
cytial virus (RSV) is the major cause of 
bronchitis, asthma, and severe lower respira-
tory tract disease in infants and young chil-
dren (Bitko et al., 1998). To investigate the 
detailed mechanisms of replication and bud-
ding of RSV in HNECs, and the epithelial 
cell responses including TJs, we established 
an RSV-infected model using hTERT-
transfected HNECs (Masaki et al., 2011). 
The replication and budding of RSV and the 
epithelial cell responses in HNECs were reg-
ulated via a PKCδ/HIF–1ߙ/NF–ߢB pathway 
(Masaki et al., 2011) (Figure 4). In addition, 
it is thought that the PKCδ/HIF–1α/NF–κB 
pathway, via TGF-β in an autocrine manner, 
may also be important in epithelial cell re-
sponses at a late stage after RSV infection 
(Masaki et al., 2011) (Figure 4). The control 
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Figure 4: Diagram showing signal transduc-
tion events in human nasal epithelial cells 
(HNECs) infected with RSV. The replication 
and budding of RSV and the epithelial cell re-
sponses in HNECs infected with RSV are regu-
lated via a PKCδ–HIF-1α–NF-κB pathway. The 
PKCδ–HIF-1α–NF-κB pathway, via TGF-β in an 
autocrine manner, may also be important in epi-
thelial cell responses at a late stage after RSV 
infection. 
 
 
of this pathway in HNECs may be useful not 
only for prevention of replication and bud-
ding of RSV but also in therapy for RSV-
induced respiratory pathogenesis. In fact, we 
found that humulone, which is the main con-
stituent of hop bitter acids, prevented the ex-
pression of RSV G protein, the formation of 
virus filaments, and the release of IL-8 and 
regulated on activation, normal T-cell ex-
pressed and secreted (RANTES) in a dose-
dependent manner in RSV-infected HNECs. 
The effects of humulone in RSV-infected 
HNECs may be regulated via distinct signal-
ing pathways including NF-κB (Fuchimoto 
et al., 2013). Furthermore, we showed that in 
HNECs, curcumin [1, 7-bis (4-hydroxy-3-
methoxyphenyl)-1, 6-heptadiene-3, 5dione], 
which is a major phenolic compound from 
the rhizome of the plant Curcuma longa, 
prevented the replication and budding of 
RSV, release of TNF-α and RANTES, and 
expression of RIG-I and MDA5 via its 
pharmacokinetic effects as an inhibitor of 
NF-κB, eIF-2a dephosphorylation, pro-
teasome, and cytochrome C oxidase (COX)-
2 (Obata et al., 2013) (Figure 5).  
 
 
Figure 5: Overview of signal transduction 
events in human nasal epithelial cells 
(HNECs). Cells infected with RSV are indicated 
with green arrows, and cells treated with curcu-
min, salubrinal, and MG132 are indicated with 
red arrows. Curcumin prevented the replication 
and budding of RSV and the epithelial responses 
in HNECs and strongly increased the epithelial 
barrier of HNECs via its pharmacokinetic effects. 
 
 
Pseudomonas aeruginosa causes chronic 
respiratory disease, and the elastase enzyme 
that it produces increases the permeability of 
airway epithelial cells through disruption of 
TJs. In addition, P. aeruginosa is implicated 
in prolonged chronic rhinosinusitis. We in-
vestigated the mechanisms involved in the 
disruption of TJs by P. aeruginosa elastase 
(PE) in HNECs (Nomura et al., 2014). We 
found that PE treatment transiently disrupted 
the epithelial barrier and downregulated the 
transmembrane proteins claudin-1 and -4, 
occludin, and tricellulin, but not the scaffold 
PDZ-expression proteins ZO-1 and -2 and 
adherens junction proteins E-cadherin and β-
catenin. The transient downregulation of TJ 
proteins was controlled via distinct signal 
transduction pathways such as the PKC, 
MAPK, PI3K, p38 MAPK, c-Jun N-terminal 
kinase (JNK), COX-1 and -2, and NF-κB 
pathways (Figure 6). In addition, PE transi-
ently decreased PAR2 expression, which al-
so regulated the expression of the TJ pro-
teins, and treatment with a PAR2 agonist 
prevented the downregulation of the TJ pro-
teins after PE treatment in HNECs. 
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Figure 6: Overview of signaling pathways and treatment with PE. The transient downregulation of 
the transmembrane TJ proteins by treatment with PE is controlled via distinct signal transduction 
pathways including PKC, MEK1/2, PI3K, p38 MAPK, JNK, COX-1, -2, and NF-κB. PE also transiently 
downregulates mRNA of the TJ molecules in human nasal epithelial cells. PE, Pseudomonas aeru-
ginosa elastase 
 
 
Malignant disease 
TJs are central for the regulation of para-
cellular permeability and the maintenance of 
epithelial cell polarity, and their expression 
is altered in various cancers compared with 
that in normal tissues (Sawada, 2013; Kon-
doh et al., 2011). It is thought that cancer 
cells irreversibly and progressively lose TJs, 
with dedifferentiation as a result of genetic 
and epigenetic changes (Sawada, 2013). In 
several human cancers, some TJ protein 
claudins are abnormally regulated, and there-
fore are promising molecular targets for di-
agnosis and therapy (Michl et al., 2003; 
Karanjawala et al., 2008). 
Claudin-18 has two alternatively spliced 
variants, claudin-18a1 and -18a2, which are 
highly expressed in the lung and stomach, 
respectively (Yano et al., 2008). Further-
more, a PKC–MAPK–AP-1-dependent path-
way regulates claudin-18a2 expression in 
TPA-stimulated gastric cancer cells (Yano et 
al., 2008). Claudin-18a2 is activated in a 
wide range of human malignant tumors, in-
cluding gastric, esophageal, pancreatic, lung, 
and ovarian cancers, and can be specifically 
targeted by monoclonal antibodies (Sahin et 
al., 2008). Claudin-18 is highly expressed in 
pancreatic intraepithelial neoplasia, includ-
ing precursor PanIN lesions and pancreatic 
duct carcinoma, and it serves as a diagnostic 
marker (Karanjawala et al., 2008).  
PKC is known to be dysregulated in can-
cers of the prostate, breast, colon, pancreas, 
liver, and kidney (Ali et al., 2009). Levels of 
PKCα, PKCβ1, and PKCδ are higher in pan-
creatic cancer, whereas levels of PKCε are 
higher in normal tissue (El-Rayes et al., 
2008). Claudin-18 mRNA, indicated as clau-
din-18a2, was markedly induced by TPA, 
and in well- and moderately-differentiated 
human pancreatic cancer cell lines HPAFII 
and HPAC; the protein was also strongly in-
creased (Ito et al., 2011). The upregulation of 
claudin-18 by TPA in human pancreatic can-
cer cell lines was prevented by inhibitors of 
PKCδ, PKCε, and PKCα, whereas the up-
regulation of claudin-18 by TPA in hTERT–
HPDE cells was prevented by inhibitors of 
PKCδ, PKCθ, and PKCα (Figure 3). 
Activation of JNK is essential for disas-
sembly of adherens junctions and TJs in hu-
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man keratinocytes and colonic epithelial 
cells (Naydenov et al., 2009; Lee et al., 
2009). Recently, inhibition of JNK activity 
was shown to enhance epithelial barrier 
function through differential modulation of 
claudin expression in murine mammary epi-
thelial cells (Carrozzino et al., 2009). To in-
vestigate whether tricellulin is regulated via 
a JNK pathway, human pancreatic cancer 
(HPAC) cells, highly expressed at tricellular 
contacts, were exposed to various stimuli 
such as the JNK activators anisomycin and 
the proinflammatory cytokines IL-1β, tumor 
necrosis factor (TNF)-α, and IL-1β (Kojima 
et al., 2010). Tricellulin expression and the 
barrier function were upregulated together 
with the activity of phospho-Rac1/cdc42 and 
phospho-JNK by treatment with the JNK ac-
tivator anisomycin, and suppressed not only 
by inhibitors of JNK and PKC but also by 
siRNAs of tricellulin (Kojima et al., 2010). 
Tricellulin expression was induced by treat-
ment with the proinflammatory cytokines IL-
1β, TNF-α, and IL-1β, whereas the changes 
were inhibited by a JNK inhibitor (Kojima et 
al., 2010). Furthermore, in normal HPDE 
cells, the responses of tricellulin expression 
to the various stimuli were similar to those in 
HPAC cells (Kojima et al., 2010). Tricellulin 
expression in tricellular TJs is strongly regu-
lated together with the barrier function via 
the JNK transduction pathway. These find-
ings suggest that JNK may be involved in the 
regulation of tricellular TJs, including tricel-
lulin expression and the barrier function, 
during normal remodeling of epithelial cells, 
and may prevent disruption of the epithelial 
barrier in inflammation and other disorders 
in pancreatic duct epithelial cells. 
The transcription factor Snail has a key 
role in epithelial–mesenchymal transition 
(EMT) during development and in tumor 
progression via negative regulation of ad-
herens junction and TJ molecules such as E-
cadherin, claudins, and occludin (Nieto, 
2002; Batlle, 2000; Cano et al., 2000; Ike-
nouchi et al., 2003). EMT is characterized by 
a loss of cell–cell contact and apicobasal po-
larity, which are hallmarks of dysfunction of 
the TJ fence (Balda et al., 1996; Lee et al., 
2006). The repression of tricellulin is also 
related to Snail-induced EMT in human gas-
tric carcinoma (Masuda et al., 2010). On the 
other hand, MarvelD3 was transcriptionally 
downregulated in poorly differentiated pan-
creatic cancer cells (Kojima et al., 2011). It 
was also downregulated during Snail-
induced EMT of pancreatic cancer cells, in 
which Snail was highly expressed and the 
fence function downregulated, whereas it 
was maintained in well-differentiated HPAC 
cells and normal pancreatic duct epithelial 
cells (Kojima et al., 2011). Depletion of 
marvelD3 by siRNAs in HPAC cells resulted 
in downregulation of barrier functions, indi-
cated by a decrease in transepithelial electric 
resistance and an increase of permeability to 
fluorescent dextran tracers, whereas it did 
not affect the fence function of TJs (Table 2) 
(Kojima et al., 2011). These results suggest-
ed that marvelD3 is transcriptionally down-
regulated in Snail-induced EMT during the 
progression of pancreatic cancer. 
The exogenous ligand EGF is one of the 
important growth factors that promote bio-
logical responses, including cell prolifera-
tion, differentiation, and migration in normal 
cells, whereas EGF is linked to malignant 
transformation in epithelial cancer cells 
(Price et al., 1996; Tobita et al., 2003; Zuo et 
al., 2011). EGF induces EMT in ovarian sur-
face epithelium via distinct signaling trans-
duction pathways (Ahmed et al., 2006). Fur-
thermore, EGF signaling modulates expres-
sion of claudins with changes in fence and 
barrier functions in various cell types (Koji-
ma et al., 2004; Singh and Harris, 2004; 
Chen et al., 2005; Flores-Benítez et al., 
2007; Singh et al., 2007; Ikari et al., 2009, 
2011). We demonstrated that EGF downreg-
ulated claudin-3 in mucinous cystadenocar-
cinoma (MCAS) cells and claudin-4 in se-
rous cystadenocarcinoma (HUOA) cells by 
inducing degradation of the proteins with 
changes in the structures and functions of 
TJs (Ogawa et al., 2012). In addition, in 
HUOA cells but not MCAS cells, EGF 
downregulated the cytotoxic effect of CPE 
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via claudin-4, and the mechanisms of the 
regulation of claudins by EGF differed be-
tween the subtypes of epithelial ovarian can-
cer cells in vitro (Ogawa et al., 2012). In 
summary, although EGF modulated claudins 
and TJ functions via MEK–ERK and PI3K–
Akt signaling pathways in epithelial ovarian 
cancer cells, there were different mecha-
nisms for the regulation of claudins by EGF 
between the subtypes in vitro. 
 
CONCLUDING REMARKS 
Cellular TJs play a crucial role in main-
taining homeostasis and in preventing dis-
ease. Until now, research on TJs has been 
targeted at the cellular level. However, there 
have been few studies on TJs at the molecu-
lar level. TJ proteins are elaborately regulat-
ed by various stimuli, such as cytokines, 
chemokines, hormones, and growth factors, 
via distinct signal transduction pathways. 
The signaling pathways, mainly the PKC–
MAPK–NF-κB pathway, affect the expres-
sion of TJ proteins and the barrier function in 
various organs or cells. The regulation of TJ 
molecules, including claudins, via signal 
transductions in normal cells is a potentially 
important therapeutic target in human dis-
ease. However, details of changes to signal-
ing pathways required to regulate TJs remain 
unclear. Because signaling pathways are 
complex and many are cross-linked, it is dif-
ficult to determine the details of complete 
signaling pathways. Further extensive re-
search is needed to clarify the role of TJs in 
signal transduction. 
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